Back to EGRX

EAGLE PHARMACEUTICALS, INC. 10-Q

Accession 0000827871-20-000014

Filing information

CIK
0000827871
Report date
2020-03-31
Filing date
2020-05-11
Form
10-Q
Primary document
egrxq120202.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.